Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease
暂无分享,去创建一个
Mario Cortina-Borja | Naomi Hammond | Panos Deloukas | Cornelia M. van Duijn | Onofre Combarros | Ignacio Mateo | Reinhard Heun | Olivia Belbin | Kevin Morgan | Gordon K. Wilcock | Jonathan A. Prince | Patrick G. Kehoe | P. Deloukas | C. Duijn | K. Morgan | K. Brown | A. Smith | P. Kehoe | M. Breteler | O. Combarros | I. Mateo | V. Álvarez | Naomi Hammond | C. Ibrahim-Verbaas | D. Lehmann | D. Warden | C. Medway | E. Coto | J. Prince | H. Kölsch | G. Wilcock | O. Belbin | R. Heun | M. Cortina-Borja | M. Schuur | J. Turton | Heike Kölsch | Kristelle Brown | Christopher Medway | Victoria Alvarez | Eliecer Coto | Maaike Schuur | R. Barber | James Bullock | Carla A. Ibrahim-Verbaas | Monique M. Breteler | Donald J. Lehmann | Donald R. Warden | Michael G. Lehmann | James M. Bullock | James C. Turton | Rachel Barber | A. David Smith | Naomi Hammond
[1] D. Stephan,et al. A survey of genetic human cortical gene expression , 2007, Nature Genetics.
[2] N. Robakis,et al. Immunohistochemical evidence of antioxidant stress in Alzheimer's disease , 1992 .
[3] P. Deloukas,et al. Interaction of insulin and PPAR-α genes in Alzheimer’s disease: the Epistasis Project , 2012, Journal of Neural Transmission.
[4] T. Hudson,et al. A genome-wide association study identifies novel risk loci for type 2 diabetes , 2007, Nature.
[5] John X. Morris,et al. The diagnosis of Alzheimer's disease. , 1999, Journal of Alzheimer's disease : JAD.
[6] O. Maes,et al. A GSTM3 polymorphism associated with an etiopathogenetic mechanism in Alzheimer disease , 2010, Neurobiology of Aging.
[7] M. McCarthy,et al. Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes , 2007, Science.
[8] R. Tanzi,et al. The current status of Alzheimer's disease genetics: what do we tell the patients? , 2004, Pharmacological research.
[9] L. Kiemeney,et al. Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.
[10] Nick C Fox,et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.
[11] K. Mossman. The Wellcome Trust Case Control Consortium, U.K. , 2008 .
[12] Nick C Fox,et al. Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .
[13] E. Sonnhammer,et al. Global networks of functional coupling in eukaryotes from comprehensive data integration. , 2009, Genome research.
[14] Andrew D. Johnson,et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap , 2008, Bioinform..
[15] Sudha Seshadri,et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.
[16] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[17] J. Lear,et al. Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. , 1996, Cancer research.
[18] P. Bosco,et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease , 2009, Nature Genetics.
[19] P. Deloukas,et al. The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project , 2010, BMC Medical Genetics.
[20] Vladimir V. Frolkis,et al. Neurobiology of Aging , 2019, Psychobiology of Behaviour.
[21] B. Mannervik,et al. Glutathione transferases--structure and catalytic activity. , 1988, CRC critical reviews in biochemistry.
[22] Judy H. Cho,et al. Finding the missing heritability of complex diseases , 2009, Nature.
[23] L. Liang,et al. A genome-wide association study of global gene expression , 2007, Nature Genetics.
[24] P. Deloukas,et al. Interactions between PPAR-α and inflammation-related cytokine genes on the development of Alzheimer's disease, observed by the Epistasis Project. , 2012, International journal of molecular epidemiology and genetics.
[25] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[26] Hagit Shatkay,et al. F-SNP: computationally predicted functional SNPs for disease association studies , 2007, Nucleic Acids Res..
[27] Arshad Khan,et al. SNPnexus: a web database for functional annotation of newly discovered and public domain single nucleotide polymorphisms , 2008, Bioinform..
[28] L. Hersh,et al. Susceptibility of amyloid beta peptide degrading enzymes to oxidative damage: a potential Alzheimer's disease spiral. , 2005, Biochemistry.
[29] M. Tao,et al. Quantitative assessment of the influence of hematopoietically expressed homeobox variant (rs1111875) on type 2 diabetes risk. , 2011, Molecular genetics and metabolism.
[30] Mario Cortina-Borja,et al. Open Access Journal of Neuroinflammation Replication by the Epistasis Project of the Interaction between the Genes for Il-6 and Il-10 in the Risk of Alzheimer's Disease , 2022 .
[31] D. Butterfield,et al. Protein oxidation in the brain in Alzheimer's disease , 2001, Neuroscience.
[32] Yurii S. Aulchenko,et al. Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project , 2012, Neurobiology of Aging.
[33] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[34] S. Mirra,et al. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. , 1993, Archives of pathology & laboratory medicine.
[35] L. Feuk,et al. Mutation screening of a haplotype block around the insulin degrading enzyme gene and association with Alzheimer's disease , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[36] F. Jessen,et al. Gene variations in GSTM3 are a risk factor for Alzheimer's disease , 2009, Neurobiology of Aging.
[37] W. Bateson. Mendel's Principles of Heredity , 1910, Nature.
[38] V. Pankratz,et al. Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aß, and Alzheimer's Disease , 2010, PloS one.
[39] L. Goldstein,et al. Axonal Transport of Amyloid Precursor Protein Is Mediated by Direct Binding to the Kinesin Light Chain Subunit of Kinesin-I , 2000, Neuron.
[40] Mario Cortina-Borja,et al. Epistasis in sporadic Alzheimer's disease , 2009, Neurobiology of Aging.
[41] Mario Cortina-Borja,et al. The synergy factor: a statistic to measure interactions in complex diseases , 2009, BMC Research Notes.
[42] E. Gallagher,et al. Several glutathione S-transferase isozymes that protect against oxidative injury are expressed in human liver mitochondria. , 2006, Biochemical pharmacology.
[43] Thomas W. Mühleisen,et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2013, Nature Genetics.
[44] V. Fraifeld,et al. Glutathione S-transferase hGSTM3 and ageing-associated neurodegeneration: relationship to Alzheimer's disease , 2005, Mechanisms of Ageing and Development.
[45] D. Kioussis,et al. The homeobox gene Hex is required in definitive endodermal tissues for normal forebrain, liver and thyroid formation. , 2000, Development.
[46] N. Biswas,et al. Increased risk of oral cancer in relation to common Indian mitochondrial polymorphisms and Autosomal GSTP1 locus , 2007, Cancer.